Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Fold change in gene expression of CRYβB2-overexpressing cells compared to control cells

From: A functional role for the cancer disparity-linked genes, CRYβB2 and CRYβB2P1, in the promotion of breast cancer

Gene symbol Name Fold
IL1RN Interleukin 1 receptor antagonist 15.07
MMP13 Matrix metallopeptidase 13 12.38
IL1B Interleukin 1 beta 9.45
TSHR Thyroid-stimulating hormone receptor 5.92
IGF1 Insulin-like growth factor 1 4.93
CDH11 Cadherin 11, type 2, OB-cadherin 4.66
MMP3 Matrix metallopeptidase 3 4.41
FLT4 Fms-related tyrosine kinase 4 3.87
ITGB3 Integrin, beta 3 3.39
MMP9 Matrix metallopeptidase 3.39
VCAN Versican 3.14
SOX10 Transcription factor SOX-10 2.61
SSTR2 Somatostatin receptor 2 2.53
CTSL Cystatin F 2.48
RORB RAR-related orphan receptor B 2.38
TMEM132A Glucose-regulated protein, 78 kDa 2.14
CDH6 Cadherin 6, type 2, K-cadherin − 10.62
FGFBP1 Fibroblast growth factor binding Prot. 1 − 7.78
WNT5B Wnt family member 5B − 7.32
CDH1 Cadherin 1, type 1, E-cadherin − 6.33
COL3A1 Collagen, type III, alpha 1 − 5.63
DSP Desmoplakin − 5.09
CDKN2A Cyclin-dependent kinase inhibitor 2A, p16 − 4.79
MAP1B Microtubule-associated protein 1B − 4.22
TGFB2 Transforming growth factor beta 2 − 3.88
MST1R Macrophage-stimulating 1 receptor − 3.14
DSC2 Desmocollin 2 − 2.93
WNT11 Wnt family member 11 − 2.75
MTSS1 Metastasis suppressor 1 − 2.68
KISS1R KiSS-1 metastasis-suppressor receptor − 2.28
ITGA7 Integrin, alpha 7 − 2.2
FGFR4 Fibroblast growth factor receptor 4 − 2.18